NasdaqGM:PRCTMedical Equipment
A Look At PROCEPT BioRobotics (PRCT) Valuation As Investors Await Rescheduled Earnings Call And Investor Day
PROCEPT BioRobotics (PRCT) is back in focus after rescheduling its fourth quarter 2025 earnings call and in person Investor Day, with investors watching for fresh guidance and multi year targets under new CEO Larry Wood.
See our latest analysis for PROCEPT BioRobotics.
At a share price of $27.26, PROCEPT BioRobotics has seen weaker momentum recently, with a 30 day share price return of a 6.42% decline and a 1 year total shareholder return of a 56.53% loss. This helps explain why the...